Register to receive a free U.S. Market Report Suite for Gynecological Devices report synopsis and brochure
According to a new series of reports on the U.S. gynecological device market by iData Research, the rigid hysteroscope market is the largest segment of the overall U.S. hysteroscope market. Growth in this market will be due to trends towards devices with more advanced optic technology and better image quality. This will increase overall market value by raising the average selling price (ASP). Flexible hysteroscopes are generally only used in diagnostic procedures, whereas rigid hysteroscopes can be used in both diagnostic and operative procedures.
The hysteroscope market is benefiting from the transcervical sterilization market, which requires the hysteroscopic placement of devices. The rigid varieties are more versatile than their flexible counterparts and therefore are in higher demand within hospitals and offices. Unit sales will rise due to an increased number of procedures that are expected to be performed.
As the population ages, the use of hysteroscopes will increase due to a higher incidence of both diagnostic and therapeutic procedures arising from conditions associated with a more mature female demographic. These procedures include transcervical sterilizations, fertility examinations and abnormal uterine bleeding. The number of diagnostic and operative procedures for uterine conditions should increase slightly, resulting in a higher demand for these devices.
The main driver behind the increase in hysteroscopy procedure numbers is the aging population in the United States. Many conditions that require hysteroscopy are more evident in the older female demographics. Moreover, hysteroscopy plays a large part in fertility assistance as it can be used in the determination of uterine abnormalities. As couples are increasingly opting to undergo assisted reproduction technology procedures and to obtain fertility assistance, it is expected that hysteroscopy procedures will also see a corresponding growth.
Many newer procedures can be done in the office as opposed to a hospital setting, increasing the number of office-based procedures performed. Moreover, the number of office-based procedures is growing because patients do not want to go to the hospital and undergo general anesthetic. Office-based procedures are faster and have a lower level of discomfort. In addition, many procedures have higher reimbursement levels in the office than in a hospital setting. This is causing more physicians to purchase hysteroscopes for their office.
“This is a relatively mature market with several competitors, creating a situation where sudden or dramatic increases in ASP will be suppressed,” explains Dr. Kamran Zamanian, CEO of iData. “Therefore the growth rate of hysteroscope prices should remain steady.”
Olympus is leading both the rigid and flexible U.S. hysteroscope markets. In addition to general hysteroscopes, Olympus has rigid hysteroscopes that are optimized for either therapeutic or diagnostic use that can be inserted without anesthetic or cervical dilation. Karl Storz is the second leading competitor in hysteroscope device market. Among the many hysteroscopes that the company produces, their BETTOCCHI® hysteroscopes are specially designed for out-patient use. Other competitors in the hysteroscope market include Richard Wolf, Stryker, Hologic and Ethicon.
For Further Information
More on the hysteroscope market in the United States can be found in a report suite published by iData Research entitled the U.S. Market Report Suite for Gynecological Devices.